{"count": 9, "results": [{"_id": "34895042", "pmid": 34895042, "pmcid": "PMC8809937", "title": "Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p/HIF-1alpha axis", "journal": "Bioengineered", "authors": ["Tian H", "Qiang T", "Wang J", "Ji L", "Li B"], "date": "2021-12-01T00:00:00Z", "doi": "10.1080/21655979.2021.1999552", "meta_date_publication": "2021 Dec", "meta_volume": "12", "meta_issue": "2", "meta_pages": "11898-11908", "score": 50294.016, "text_hl": "This study aimed to explore the bioregulation of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and its mechanism in @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@acute leukemia@@@ cell lines. ", "citations": {"NLM": "Tian H, Qiang T, Wang J, Ji L, Li B. Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p/HIF-1alpha axis Bioengineered. 2021 Dec;12(2):11898-11908. PMID: 34895042", "BibTeX": "@article{34895042, title={Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p/HIF-1alpha axis}, author={Tian H and Qiang T and Wang J and Ji L and Li B}, journal={Bioengineered}, volume={12}, number={2}, pages={11898-11908}}"}}, {"_id": "37847357", "pmid": 37847357, "pmcid": "PMC10676344", "title": "Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways", "journal": "Drugs R D", "authors": ["Li G", "Yao J", "Lu Z", "Yu L", "Chen Q", "Ding L", "Fang Z", "Li Y", "Xu B"], "date": "2023-10-17T00:00:00Z", "doi": "10.1007/s40268-023-00442-6", "meta_date_publication": "2023 Oct 17", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50288.254, "text_hl": "...Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@AML@@@ cell proliferation. ", "citations": {"NLM": "Li G, Yao J, Lu Z, Yu L, Chen Q, Ding L, Fang Z, Li Y, Xu B. Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways Drugs R D. 2023 Oct 17;():. PMID: 37847357", "BibTeX": "@article{37847357, title={Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways}, author={Li G and Yao J and Lu Z and Yu L and Chen Q and Ding L and Fang Z and Li Y and Xu B}, journal={Drugs R D}}"}}, {"_id": "22120639", "pmid": 22120639, "title": "Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patients.", "journal": "Exp Hematol", "authors": ["van der Weide K", "de Jonge-Peeters S", "Huls G", "Fehrmann RS", "Schuringa JJ", "Kuipers F", "de Vries EG", "Vellenga E"], "date": "2012-03-01T00:00:00Z", "doi": "10.1016/j.exphem.2011.11.008", "meta_date_publication": "2012 Mar", "meta_volume": "40", "meta_issue": "3", "meta_pages": "177-186.e6", "score": 50069.723, "text_hl": "Treatment with high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ inhibits geranylgeranylation in @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@AML@@@ blast cells in a subset of @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@AML@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "van der Weide K, de Jonge-Peeters S, Huls G, Fehrmann RS, Schuringa JJ, Kuipers F, de Vries EG, Vellenga E. Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patients. Exp Hematol. 2012 Mar;40(3):177-186.e6. PMID: 22120639", "BibTeX": "@article{22120639, title={Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patients.}, author={van der Weide K and de Jonge-Peeters S and Huls G and Fehrmann RS and Schuringa JJ and Kuipers F and de Vries EG and Vellenga E}, journal={Exp Hematol}, volume={40}, number={3}, pages={177-186.e6}}"}}, {"_id": "21931323", "pmid": 21931323, "title": "Heterogeneity in simvastatin-induced cytotoxicity in AML is caused by differences in Ras-isoprenylation.", "journal": "Leukemia", "authors": ["van der Weide K", "Korthuis PM", "Kuipers F", "de Vries EG", "Vellenga E"], "date": "2012-04-01T00:00:00Z", "doi": "10.1038/leu.2011.259", "meta_date_publication": "2012 Apr", "meta_volume": "26", "meta_issue": "4", "meta_pages": "845-8", "score": 50065.96, "text_hl": "Heterogeneity in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@cytotoxicity@@@ in @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@AML@@@ is caused by differences in Ras-isoprenylation.", "citations": {"NLM": "van der Weide K, Korthuis PM, Kuipers F, de Vries EG, Vellenga E. Heterogeneity in simvastatin-induced cytotoxicity in AML is caused by differences in Ras-isoprenylation. Leukemia. 2012 Apr;26(4):845-8. PMID: 21931323", "BibTeX": "@article{21931323, title={Heterogeneity in simvastatin-induced cytotoxicity in AML is caused by differences in Ras-isoprenylation.}, author={van der Weide K and Korthuis PM and Kuipers F and de Vries EG and Vellenga E}, journal={Leukemia}, volume={26}, number={4}, pages={845-8}}"}}, {"_id": "7967748", "pmid": 7967748, "title": "Selective inhibition of primary acute myeloid leukaemia cell growth by simvastatin.", "journal": "Leukemia", "authors": ["Newman A", "Clutterbuck RD", "Powles RL", "Millar JL"], "date": "1994-11-01T00:00:00Z", "meta_date_publication": "1994 Nov", "meta_volume": "8", "meta_issue": "11", "meta_pages": "2023-9", "score": 50065.676, "text_hl": "The differential effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on normal and leukaemic progenitor cells may have value in the clinical management of @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@AML@@@. ", "citations": {"NLM": "Newman A, Clutterbuck RD, Powles RL, Millar JL. Selective inhibition of primary acute myeloid leukaemia cell growth by simvastatin. Leukemia. 1994 Nov;8(11):2023-9. PMID: 7967748", "BibTeX": "@article{7967748, title={Selective inhibition of primary acute myeloid leukaemia cell growth by simvastatin.}, author={Newman A and Clutterbuck RD and Powles RL and Millar JL}, journal={Leukemia}, volume={8}, number={11}, pages={2023-9}}"}}, {"_id": "31452046", "pmid": 31452046, "title": "Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells.", "journal": "Mol Biol Rep", "authors": ["Jang J", "Lee J", "Jang JH", "Jung CW", "Park S"], "date": "2019-12-01T00:00:00Z", "doi": "10.1007/s11033-019-05019-8", "meta_date_publication": "2019 Dec", "meta_volume": "46", "meta_issue": "6", "meta_pages": "5859-5866", "score": 50063.387, "text_hl": "Anti-@DISEASE_Leukemia @DISEASE_MESH:D007938 @@@leukemic@@@ effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on NRASG12D mutant @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@acute myeloid leukemia@@@ cells.", "citations": {"NLM": "Jang J, Lee J, Jang JH, Jung CW, Park S. Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells. Mol Biol Rep. 2019 Dec;46(6):5859-5866. PMID: 31452046", "BibTeX": "@article{31452046, title={Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells.}, author={Jang J and Lee J and Jang JH and Jung CW and Park S}, journal={Mol Biol Rep}, volume={46}, number={6}, pages={5859-5866}}"}}, {"_id": "7614073", "pmid": 7614073, "title": "The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.", "journal": "J Investig Med", "authors": ["Newman A", "Clutterbuck RD", "DeLord C", "Powles RL", "Catovsky D", "Millar JL"], "date": "1995-06-01T00:00:00Z", "meta_date_publication": "1995 Jun", "meta_volume": "43", "meta_issue": "3", "meta_pages": "269-74", "score": 50060.56, "text_hl": "We conclude that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ may be an effective in vitro purging agent in ABMT for @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@AML@@@.", "citations": {"NLM": "Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. J Investig Med. 1995 Jun;43(3):269-74. PMID: 7614073", "BibTeX": "@article{7614073, title={The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.}, author={Newman A and Clutterbuck RD and DeLord C and Powles RL and Catovsky D and Millar JL}, journal={J Investig Med}, volume={43}, number={3}, pages={269-74}}"}}, {"_id": "19383813", "pmid": 19383813, "title": "Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples.", "journal": "Clin Cancer Res", "authors": ["van der Weide K", "de Jonge-Peeters SD", "Kuipers F", "de Vries EG", "Vellenga E"], "date": "2009-05-01T00:00:00Z", "doi": "10.1158/1078-0432.CCR-08-3004", "meta_date_publication": "2009 May 1", "meta_volume": "15", "meta_issue": "9", "meta_pages": "3076-83", "score": 50059.516, "text_hl": "In primary sorted @GENE_CD34 @GENE_947 @@@CD34@@@(+) @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@AML@@@ cells, a heterogeneous response pattern was observed upon treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ when analyzing cell survival. ", "citations": {"NLM": "van der Weide K, de Jonge-Peeters SD, Kuipers F, de Vries EG, Vellenga E. Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples. Clin Cancer Res. 2009 May 1;15(9):3076-83. PMID: 19383813", "BibTeX": "@article{19383813, title={Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples.}, author={van der Weide K and de Jonge-Peeters SD and Kuipers F and de Vries EG and Vellenga E}, journal={Clin Cancer Res}, volume={15}, number={9}, pages={3076-83}}"}}, {"_id": "11478407", "pmid": 11478407, "title": "Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines.", "journal": "J Investig Med", "authors": ["Lishner M", "Bar-Sef A", "Elis A", "Fabian I"], "date": "2001-07-01T00:00:00Z", "doi": "10.2310/6650.2001.33896", "meta_date_publication": "2001 Jul", "meta_volume": "49", "meta_issue": "4", "meta_pages": "319-24", "score": 50059.5, "text_hl": "CONCLUSIONS: We conclude that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ has a major antiproliferative effect on @<m>DISEASE_Leukemia_Myeloid_Acute</m> @DISEASE_MESH:D015470 @@@AML@@@ blasts in vitro. ", "citations": {"NLM": "Lishner M, Bar-Sef A, Elis A, Fabian I. Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines. J Investig Med. 2001 Jul;49(4):319-24. PMID: 11478407", "BibTeX": "@article{11478407, title={Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines.}, author={Lishner M and Bar-Sef A and Elis A and Fabian I}, journal={J Investig Med}, volume={49}, number={4}, pages={319-24}}"}}]}